You are viewing the "Brian Mann | NPR" Archives
One woman’s controversial fight to make America accept drug users for who they are
When Louise Vincent was introduced at a drug policy conference last month in Phoenix, the huge crowd erupted in applause. She’s a small woman, rail thin. At age 47, her… Read More
Rural voters shaping the GOP presidential turn against U.S. aid to Ukraine
WASHINGTON (NPR) — A growing number of conservative Americans — especially those in rural communities — say it’s time for military and financial aid to Ukraine to end. U.S. support… Read More
Supreme Court temporarily blocks $6 billion Purdue Pharma-Sackler bankruptcy
WASHINGTON (NPR) — The U.S. Supreme Court has agreed to review a controversial bankruptcy case involving Purdue Pharma, the maker of Oxycontin, and members of the Sackler family who own… Read More
Only 1 in 5 people with opioid addiction get the medications to treat it, study finds
WASHINGTON (NPR) — Imagine if during a deadly public health crisis, 80% of Americans weren’t able to get safe, effective medications proven to help people recover. A study published Monday… Read More
The Biden administration says fentanyl-xylazine cocktail is a deadly national threat
WASHINGTON (NPR) — The U.S. government issued a grave new warning Wednesday about a cocktail of illegal street drugs made of fentanyl and xylazine that’s fueling another wave of American… Read More
People addicted to opioids rarely get life-saving medications. That may change.
WASHINGTON, D.C. (NPR) — Doctors and researchers have known for decades that safe, easy-to-use medications are a game-changer for people addicted to opioids. Buprenorphine and methadone reduce cravings for opioids… Read More
Republicans won House seats in blue New York. Those wins could help shape Congress
WASHINGTON, D.C. (NPR) — When Republicans take control of the U.S. House next month, they’ll have voters in New York to thank for roughly a third of their national gains…. Read More
Is ‘rainbow fentanyl’ a threat to your kids this Halloween? Experts say no
WASHINGTON, D.C. (NPR) — The U.S. Drug Enforcement Administration has been raising a terrifying alarm in recent weeks. According to the DEA, bright-colored fentanyl pills designed to hook children have… Read More
4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis
WASHINGTON, D.C. (NPR) — Four of the largest U.S. corporations have agreed to pay roughly $26 billion to settle a tsunami of lawsuits linked to claims that their business practices… Read More
Corporate opioid payouts now being finalized would top $32 billion
WASHINGTON, D.C. (NPR) — Over the next two weeks, some of the biggest U.S. corporations accused of “turbocharging” the opioid epidemic could finalize payouts to victims and governments worth roughly… Read More
Kentucky crews search painstakingly for 109 people missing after deadly tornadoes
Under a chilly blue sky, a dozen men and women stood in a line on a devastated street in Dawson Springs, Ky., one of the small towns hit hardest by… Read More
A jury in Ohio says America’s big pharmacy chains are liable for the opioid epidemic
CLEVELAND (NPR) — A federal jury on Tuesday found three of the nation’s biggest pharmacy chains, CVS, Walgreens and Walmart, liable for helping to fuel the U.S. opioid crisis. Jurors… Read More
A Federal Judge Rejects A Government Bid To Delay Purdue Pharma’s Bankruptcy Settlement
Updated October 14, 2021 at 8:43 AM NEW YORK (NPR) — In a surprise ruling late Wednesday a federal judge in New York allowed work to continue on implementation of… Read More
Purdue Pharma Offers Restructuring Plan, Sackler Family Would Give Up Ownership
Under a bankruptcy plan filed late Monday, the OxyContin maker would pay $500 million up front, promising billions in future payments. Twenty-four states rejected the proposal.
Consulting Giant McKinsey To Settle Opioid Claims For $573 Million
McKinsey is the latest major American corporation to face legal, financial and public relations peril stemming from its role in the nation’s deadly opioid epidemic.
Opioid Scandal Haunts Drug Companies As They Respond To Pandemic
Thousands of lawsuits that ground to a halt because of COVID-19 are moving forward again as local, state and federal courts reopen around the U.S.
Architecture For Landmark Nationwide Opioid Settlement Unveiled
If finalized, such a deal could funnel tens of billions of dollars to American communities struggling with the addiction crisis, while restoring stability to one of the country’s biggest industries.